Yong Yu, VP, Clinical Trial Operations at GENELUX Corp (GNLX), sold 65,070 shares at $14.18 ($856K) on 2023-12-15, disclosed to the SEC on 2023-12-18.
Open-market sale of $856k GNLX by VP, Clinical Trial Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.94 | 26,732 | $346K | 40.4% |
| 2 | $12.94 | 26,732 | $346K | 40.4% |
| 3 | $14.18 | 5,803 | $82K | 9.6% |
| 4 | $14.18 | 5,803 | $82K | 9.6% |
| Total | $13.16 avg | 65,070 | $856K | 100% |
| Filing → |
| GNLX | SELL | 2026-05-12 | $2K | — | Filing → |
| GNLX | SELL | 2026-03-26 | $2K | — | Filing → |
| GNLX | SELL | 2025-12-11 | $16K | — | Filing → |